JER5:XETRA:XETRA-JPMorgan ETFs Ireland ICAV - EUR Corporate Bond 1-5 yr Research Enhanced Index ESG UCITS ETF EUR Acc (EUR)

ETF | Others |

Last Closing

USD 104.57

Change

+0.10 (+0.10)%

Market Cap

USD 0.12B

Volume

82.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.41 (+0.79%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.77%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.21 (+0.73%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.41%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.01%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.78%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.19 (+0.20%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.48 (+0.27%)

USD 80.38B

ETFs Containing JER5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.52% 31% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.52% 30% F 35% F
Trailing 12 Months  
Capital Gain 7.85% 27% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.85% 26% F 32% F
Trailing 5 Years  
Capital Gain 1.69% 29% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.69% 28% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain -0.13% N/A N/A 28% F
Dividend Return -0.13% N/A N/A 27% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.40% N/A N/A 91% A-
Risk Adjusted Return -3.04% N/A N/A 26% F
Market Capitalization 0.12B 36% F 32% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.